SCHEMBL6564515

SCHEMBL6564515

COC(=O)c1cc(N)ccc1OC(c1ccccc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
TDO2 P48775 1/20 0.46
IDO2 Q6ZQW0 1/20 0.46
GAA P10253 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CASR P41180 1/20 0.39
POLB P06746 1/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SLC6A2 P23975 4/20 0.38
SLC6A4 P31645 4/20 0.38
SLC6A3 Q01959 4/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 3/20 0.38
KCNH2 Q12809 3/20 0.38
S1PR4 O95977 1/20 0.38
S1PR3 Q99500 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565805 0.90 ABL1 (0.44) IDO1TDO2GAAMEN1KMT2A
SCHEMBL6564533 0.89 GAA (0.48) GAAMEN1KMT2AKDM4EHSD17B10
SCHEMBL6565855 0.88 ABL1 (0.42) GAAMEN1KMT2AKDM4EHSD17B10
SCHEMBL6565892 0.85 IDO1 (0.44) IDO1TDO2IDO2GAAMEN1
SCHEMBL6564586 0.85 SLC6A4 (0.42) GAAMEN1KMT2AKDM4EHSD17B10
SCHEMBL6564770 0.84 GAA (0.39) GAAMEN1KMT2AKDM4EHSD17B10
SCHEMBL6566010 0.83 IDO1 (0.48) IDO1TDO2GAAMEN1KMT2A
SCHEMBL6564639 0.82 CFTR (0.47) IDO1TDO2GAACASR
SCHEMBL6566689 0.82 ALDH1A1 (0.40) GAAMEN1KMT2AKDM4ELMNA
SCHEMBL6566566 0.82 ABL1 (0.39) IDO1TDO2GAAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 IDO1 953/4885TDO2 675/4885IDO2 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.